Antiamoebic drugs for treating amoebic colitis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Gonzales, Maria Liza M ^a   Dans, Leonila F ^b   Martinez, Elizabeth G ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIAMEBIC AGENT; BISMUTH GLYCOARSANILATE; CHLORBETAMIDE; CHLORHYDROXQUINOLINE; CLEFAMIDE; CLIOQUINOL; CLOXIQUINE; DEHYDROEMETINE; DIIODOHYDROXYQUIN; DIIODOHYDROXYQUIN PLUS METRONIDAZOLE; DILOXANIDE FUROATE; DIMETHYCHLORTETRACYCLINE; ETOPHAMIDE; FURAZOLIDONE PLUS METRONIDAZOLE; MEBENDAZOLE; METRONIDAZOLE; METROZOL; MK 910; NIMORAZOLE; NITAZOXANIDE; ORNIDAZOLE; OXYTETRACYCLINE; PANIDAZOLE; PAROMOMYCIN; PHENANTHRONDIONE; QUGYL; QUINFAMIDE; SATRANIDAZOLE; SECNIDAZOLE; TETRACYCLINE; TINIDAZOLE; TYNAZOLE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; AMEBIASIS; APPETITE; BITTER TASTE; CLINICAL TRIAL; COLIC; DIARRHEA; DIZZINESS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENTAMOEBA HISTOLYTICA; FECES ANALYSIS; HAND PARESTHESIA; HEADACHE; HUMAN; META ANALYSIS; MONOTHERAPY; NAUSEA; RELAPSE; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SPEECH DISORDER; SYSTEMATIC REVIEW; TASTE; TREATMENT DURATION; TRICHURIASIS; UNSPECIFIED SIDE EFFECT; VOMITING;

EID: 70349162870     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006085.pub2     Document Type: Review

References (277)

1. Asrani CH, Damle SS, Ghotge VV, Gokhale AS, Jalgaonkar M, Pai Kakode PR, et al.Efficacy and safety of metronidazole versus a combination of metronidazole and diiodohydroxyquinoline for the treatment of patients with intestinal amebiasis: a Primary Care Physician Research Group Study. Current Therapeutic Research 1995;56(7): 678-683
2. Awal ARMA, Ali S. Tinidazole in the treatment of symptomatic intestinal amoebiasis. Current Therapeutic Research 1979;26(6):962-966 (Pubitemid 10215531)
3. Batra SK, Ajmani NK, Chuttani HK. Evaluation of 1-methyl-2-(4'- fluorophenyl)-5-nitroimidazole. Journal of Tropical Medicine and Hygiene 1972;75(2):40-41
4. Botero D. Double blind study with a new nitroimidazole derivative, Ro 7-0207, versus metronidazole in symptomatic intestinal amebiasis. American Journal of Tropical Medicine and Hygiene 1974;23(5): 1000-1001
5. Botero D, Perez A. Treatment of intestinal amoebiasis and vaginal trichomoniasis with panidazole and its comparison with metronidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 1977;71(6):508-511
6. Chunge CN, Estambale BB, Pamba HO, Chitayi PM, Munanga PN, Kang'ethe S.Comparison of four nitroimidazole compounds for treatment of symptomatic amoebiasis in Kenya. East African Medical Journal 1989;66(11):724-727
7. Davila-Gutierrez C, Vasquez C, Trujillo-Hernandez B, Huerta M. Nitazoxanide compared with quinfamide and mebendazole in the treatment of helminthic infections and intestinal protozoa in children. American Journal of Tropical Medicine and Hygiene 2002;66 (3):251-254 (Pubitemid 34756092)
8. Donckaster R, Atias A, Faiguenbaum J, Jarpa A, Sapunar J, Cuello E. Chronic intestinal amebiasis. Therapeutic trial of antibiotics, chemotherapeutics and placebos [Amibiasis intestinal cronica. Ensayo terapeutico con antibioticos, quimioterapicos y placebo]. Boletin Chileno de Parasitologia 1964;19:46-54.
9. Huggins D. Double-blind clinical trial with WIN 40.014 in the treatment of intestinal chronic amebiasis [Ensaio clinico duplo-cego com o WIN 40.014 no tratamento da amebiase intestinal cronica]. Folha Medica 1982;85 Suppl 1:869-870
10. Joshi HD, Shah BM. A comparative study of tinidazole and metronidazole in treatment of amoebiasis. The Indian Practitioner 1975: 295-302.
11. Kapadia RM, Pathak HY, Apte SP. Chlorhydroxyquinoline and diiodohydroxyquinoline in amoebiasis: a comparative study. Journal of the Indian Medical Association 1968;51(3):125-127
12. Karabay O, Godekmerden A. Comparison of therapeutic efficacies of the single dose secnidazole versus 10-day metronidazole in acute amebiasis [Akut intestinal amebiyaz tedavisinde tek doz seknidazol ile 10 gunluk metronidazolun etkinliklerinin karsilastirilmasi]. Klimik Dergisi 1999;12(2):82-84
13. Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World Journal of Gastroenterology 2003;9(8):1832-1833 (Pubitemid 37038141)
14. Mathur SN, Itigi A, Rao PD, Krishnaveni, Rai V. Evaluation of tinidazole in treatment of amoebiasis. Indian Medical Gazette 1976: 361-364
15. Misra NP, Laiq SM. Comparative trial of tinidazole and metronidazole in intestinal amebiasis. Current Therapeutic Research 1974;16 (12):1255-1263
16. Misra NP, Gupta RC. A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. Journal of International Medical Research 1977;5(6):434-437 (Pubitemid 8220596)
17. Misra NP. A comparative study of tinidazole and metronidazole as a single daily dose for three days in symptomatic intestinal amoebiasis. Drugs 1978;15 Suppl 1:19-22.
18. Mohammed KA, Strak SK, Jawad AM, Al-Sadoon IO, Mahdi NK. Effectiveness of praziquantel in treatment of intestinal amoebiasis and giardiasis. Eastern Mediterranean Health Journal 1998;4(1):161-163 (Pubitemid 128471040)
19. Naoemar SA, Rukmono B. Clinical trial of Ro 7-0207, a nitroimidazole derivative in amoebic dysentery. Southeast Asian Journal of Tropical Medicine and Public Health 1973;4(3):417-420
20. Nnochiri E. Oral chemotherapy in amoebic dysentery - potentiating effect of chloroquine on the action of diloxanide furoate. Journal of Tropical Medicine and Hygiene 1967;70(9):224-228
21. Padilla N,Diaz R,Munoz M. Efficacy and safety of quinfamide versus secnidazole in the management of amoebic non-dysenteric colitis in children. Clinical Drug Investigation 2000;20(2):89-93.
22. Pamba HO, Estambale BB, Chunge CN, Donno L. Comparative study of aminosidine, etophamide and nimorazole, alone or in combination, in the treatment of intestinal amoebiasis in Kenya. European Journal of Clinical Pharmacology 1990;39(4):353-357 (Pubitemid 20362345)
23. Panggabean A, Sutjipto A, Aldy D, Sutanto AH, Siregar H. Tinidazole versus ornidazole in amebic dysentery in children (a double blind trial). Paediatrica Indonesiana 1980;20(11-12):229-235 (Pubitemid 11003585)
24. Pehrson P, Bengtsson E. Treatment of non-invasive amoebiasis. A comparison between tinidazole alone and in combination with diloxanide furoate. Transactions of the Royal Society of Tropical Medicine and Hygiene 1983;77(6):845-846 (Pubitemid 14220734)
25. Pehrson P, Bengtsson E. Treatment of non-invasive amoebiasis - a comparison between tinidazole andmetronidazole. Annals of Tropical Medicine and Parasitology 1984;78(5):505-508 (Pubitemid 15200472)
26. Prasad R, Jagota SC, Mathur PP, Taneja V. Drug trial of 'Dependal' - M suspension against metronidazole suspension in amoebiasis and giardiasis. Indian Medical Gazette 1985;119(7):219-223 (Pubitemid 16219126)
27. Pudjiadi SH, Sunoto, Suharjono, Kadri N. A new oral amoebicid (RO 7-0207) in the treatment of intestinal amoebiasis. Paediatrica Indonesiana 1973;13(4):113-119
28. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide. Journal of Infectious Diseases 2001;184(3):381-384 (Pubitemid 32662190)
29. Rossignol JF, Kabil SM, El Gohary Y, Younis AM.Nitazoxanide in the treatment of amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 2007;101(10):1025-1031
30. Rubidge CJ, Scragg JN, Powell SJ. Treatment of children with acute amoebic dysentery. Comparative trial ofmetronidazole against a combination of dehydroemetine, tetracycline, and diloxanide furoate. Archives of Disease in Childhood 1970;45(240):196-197
31. Salles JMC, Bechara C, Tavares AM, Martins M, Sobrinho JG, Dietrich-Neto F, et al.Comparative study of the efficacy and tolerability of secnidazole suspension (single dose) and tinidazole suspension (two days dosage) in the treatment of amebiasis in children. Brazilian Journal of Infectious Diseases 1999;3(2):80-88
32. Singh G, Kumar S. Short course of single daily dosage treatment with tinidazole and metronidazole in intestinal amoebiasis: a comparative study. Current Medical Research and Opinion 1977;5(2):157-160 (Pubitemid 8225643)
33. Sitepu N, Lubis CP, Sutanto AH, Siregar H. Minute treatment with tinidazole and ornidazole in children with amebic dysentery. Paediatrica Indonesiana 1982;22(7-8):132-135
34. Soedin K, Alfien Syukran OK, Fadillah A, Sidabutar P. Comparison between the efficacy of a single dose of secnidazole with a 5-day course of tetracycline and clioquinol in the treatment of acute intestinal amoebiasis. Pharmatherapeutica 1985;4(4):251-254 (Pubitemid 15051625)
35. Swami B, Lavakusulu D, Devi CS. Tinidazole and metronidazole in the treatment of intestinal amoebiasis. Current Medical Research and Opinion 1977;5(2):152-156 (Pubitemid 8225642)
36. Toppare MF, Kitapci F, Senses DA, Yalcinkaya F, Safa Kaya I,Dilmen U. Ornidazole and secnidazole in the treatment of symptomatic intestinal amoebiasis in childhood. Tropical Doctor 1994;24(4):183-184 (Pubitemid 24320272)
37. Tripathi BM,Misra NP, Tiwari A. A double-blind trial of GO10213 and metronidazole in intestinal amoebiasis. Current Therapeutic Research 1986;39(2):178-182 (Pubitemid 17023631)
38. Abd-Rabbo H, Montasir M. A trial of oral dehydroemetine compounds in the treatment of amoebiasis. Journal of Tropical Medicine and Hygiene 1969;72(3):64-67
39. Abdallah A, Gad-el-Mawla N, el-Kordy MI. Erythromycin stearate in intestinal amoebiasis. Journal of the Egyptian Medical Association 1969;52(2):168-173
40. Achar ST, Rama Row GV. Clinical trials with dehydroemetine and paromomycin in acute amoebic dysentery in children. Journal of the Indian Medical Association 1967;49(8):370-372
41. Ali Ata AH, el-Raziky ES. Trials of BT 436 in amoebiasis. Zeitschrift für Tropenmedizin und Parasitologie 1967;18(3):321-326
42. Alterio DL. Clinico-parastilogological evaluation of an anti-ameba therapeutic activity of a new non-absorbable erythromycin stearate preparation [Avaliacao clinico-parasitologica da atividade terapeutica antiamebiana de uma nova preparacao de estearato de eritromicina nao absorvivel]. Hospital (Rio de Janeiro, Brazil) 1968;73(4):1207-1213
43. Amato Neto V, Wanderley RA. Use of an erythromycin stearate preparation, of regulated intestinal release in the treatment of intestinal amebiasis [Observacoes preliminares sobre o emprego de preparacao de estearato de eritromicina, de liberacao intestinal regulada, no tratamento da amebiase intestinal]. Hospital (Rio de Janeiro, Brazil) 1968;73(2):583-589
44. Apt W, Perez C, Gabor M, Doren G. Treatment of chronic amebiasis with nitrimidazole [Tratamiento de la amibiasis intestinal cronica con nimorazol]. Revista Medica de Chile 1976;104(11):791-793
45. Apt W, Perez C, Miranda C, Gabor M, Doren G. Treatment of intestinal amebiasis and giardiasis with ornidazole [Tratamiento de la amebiasis intestinal y giardiasis con ornidazole]. Revista Medica de Chile 1983;111(11):1130-1133
46. Arredondo-Cortes E, Gonzalez-Gonzales JA, Bosques-Padilla F, Elizondo Riojos G, Barragan-Villareal. A randomized controlled trial of medical treatment vs medical treatment plus puncture in amoebic liver abscess [abstract]. Gut 1993;34(3):S43.
47. Atias A, Sapunar J, Parodi V, Perez C, Gabor M, Stagno S, et al.Treatment of chronic intestinal amebiasis with teclozan [Tratamiento de la amibiasis intestinal cronica con teclozan]. Boletin Chileno de Parasitologia 1972;27:119-121
48. Bakshi JS,Ghiara JM,Nanivadekar AS.Howdoes tinidazole compare with metronidazole? A summary report of Indian trials in amoebiasis and giardiasis. Drugs 1978;15 Suppl 1:133-142
49. Banerjee RN, Singh J, Basu AK. Metronidazole in the treatment of amoebiasis. The Indian Practitioner 1976:208-216
50. Baranski MC. Treatment of chronic intestinal amebiasis with the compound of diiodohydroxyquinoline, tetracycline and chloroquine [Tratamento da amebiase intestinal cronica pela associacao de diiohidroxiquinoleina, tetraciclina e cloroquina]. Revista Brasileira de Medicina 1966;23(11):774-778
51. Barroso E, Ruiloba J. Treatment of intestinal amebiasis with eticlordifene [Tratamento de la amebiasis intestinal con eticlordifene]. Revista de Investigacion Clinica 1969;21(2):195-203.
52. Bassily S, Farid Z, El-Masry NA,Mikhail EM.Treatment of intestinal E. histolytica and G. lamblia with metronidazole, tinidazole and ornidazole: a comparative study. Journal of Tropical Medicine and Hygiene 1987;90(1):9-12. (Pubitemid 17082083)
53. Belkind-Valdovinos U, Belkind-Gerson J, Sanchez-Francia D, Espinoza-Ruiz MM, Lazcano-Ponce E. Evaluation of nitazoxanide in single dose and for three days in intestinal parasitism [Evaluacion de la nitazoxanida en dosis unica y por tres dias en parasitosis intestinal]. Salud Publica de Mexico 2004;46(3):333-340
54. Bezjak B, Breitenfeld V. Mexaform in the treatment of amoebiasis [Mexaform in der amobiasis-therapie]. Munchener Medizinische Wochenschrift 1964;106(42):1946-1956
55. Bhatia S, Karnad DR, Oak JL. Randomized double-blind trial of metronidazole versus secnidazole in amebic liver abscess. Indian Journal of Gastroenterology 1998;17(2):53-54 (Pubitemid 28180291)
56. * Biagi FF, Lopez RM,Gonzalez C, Gutierrez M. Chemoprophylaxis of amebiasis using clefamide in an open community [Quimoprofilaxis de la amibiasis con clefamida en una comunidad abierta]. Gaceta Medica de Mexico Sao Paolo 1966;96(2):183-190
57. Biagi FF, Lopez RM,Gonzalez C,Gutierrez M.Chemoprophylaxis of amebiasis using clefamide in an open community [Quimoprofilaxis de la amibiasis con clefamida en una comunidad abierta]. Revista do Instituto de Medicina Tropical de São Paulo 1966;8(5):235-240
58. Biagi F, Munoz J, Gonzalez C. Treatment of amoebiasis with drugs acting on intestinal lumen and tissue [Tratamiento de la amibiasis con medicamentos de accion luminal y tisular]. Prensa Medica Mexicana 1978;43(1-2):59-60.
59. * Blanc F, Denjean B, Felix H, Nosny Y, Pene P, Renaud R. Trial treatment of amoebiasis by oral adminsitration of 2-dehydroemetine [Essai de traitement de l'amibiase par l'administration orale de la 2-dehydroemetine]. Academie Nationale de Medecine La Presse Medicale 1965;149(16-17):360-365
60. Blanc F, Denjean B, Felix H,Nosny Y, Pene P, Reynaud R, Sankale M. Treatment of amoebiasis with oral 2-dehydroemetine [Le traitement de l'amibiase par la 2-dehydroemetine orale]. La Presse Medicale 1966;74(2):51-54
61. Blessman J, Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. New England Journal of Medicine 2002; 347(17):1384. (Pubitemid 35215340)
62. Blessman J, Binh HD, Hung DM, Tannich E, Burchard G. Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study. Tropical Medicine and International Health 2003;8(11):1030-1034 (Pubitemid 37386472)
63. Botero D. Treatment of intestinal amoebiasis with diloxanide furoate, tetracycline and chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61(6):769-773
64. Campos R. Treatment of intestinal amebiasis using erythromycin stearate under controlled release [Tratamento de amebiase intestinal pelo estearato de eritromicina de liberacao regulada]. Revista Brasileira de Medicina 1969;26(2):113-114
65. Cardoso Salles JM, Gundim Leitao E. Treatment of intestinal amebiasis using ethyl chlordiphene. Comparative study [Tratamento da amebiase intestinal com eticlordifene. Estudo comparativo]. Hospital (Rio de Janeiro, Brazil) 1970;77(6):2073-2080
66. Cariry NA, da Silva MA. Treatment of intestinal amoebiasis with teclozan (Falmonox). Comparative study of therapeutic schemes [Tratamento da amebiase intestinal com teclozan (Falmonox). Estudo comparativo de esquemas terapeuticos]. Hospital (Rio de Janeiro, Brazil) 1969;76(3):1033-1037
67. Chari MV, Gadiyar BN. A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial. American Journal of Tropical Medicine and Hygiene 1970;19(6):926-928
68. Chaudhuri RN, Saha TK. Combined therapy of amoebic dysentery. Bulletin of the Calcutta School of Tropical Medicine 1966;14(1):22.
69. Cho KM, Cha HY, Soh CT. Clinical trials of R-0207 against Entamoeba histolytica infections (double blind trials versus metronidazole). Yonsei Reports on Tropical Medicine 1972;3:123-133
70. Cohen HG, Reynolds TB.Comparison ofmetronidazole and chloroquine for the treatment of amoebic liver abscess. A controlled trial. Gastroenterology 1975;69(1):35-41.
71. da Cunha AS, da SIlva EF, de Mello SM. Clinical trial with the imidazol compound R.P. 14539 in intestinal amebiasis [Avaliacao terapeutico do composto imidazolico R.P. 14539 na amebiase intestinal]. Revista do Instituto de Medicina Tropical de São Paulo 1977;19 (5):342-348
72. Datta DV, Singh SA, Chhuttani PN. Treatment of amoebic liver abscess with emetine hydrochloride, niridazole, and metronidazole. A controlled clinical trial. American Journal of Tropical Medicine and Hygiene 1974;23(4):586-589
73. de Carvalho HT, Coura LC, da Silva JR. Treatment of intestinal amebiasis - preliminary results of a trial with a new drug, Bayer 2456 (amebicide) [Tratamento da amebiase intestinal - resultados preliminares de ensaio com um novo medicamento, o Bayer 2456 (amoebacide)]. Revista Brasileira de Medicina 1965;22(9):562-566
74. de la Rey Nel J, Simjee AE, Patel A. Indication for aspiration of amoebic liver abscess. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde 1989;75(8):373-376 (Pubitemid 19132509)
75. da Oliveira CA. Therapeutic experience in the use of erythromycin stearate in chronic intestinal amebiasis [Experiencia terapeutica com estearato de eritromicina de liberacao regulada, na amebiase intestinal cronica]. Hospital (Rio de Janeiro, Brazil) 1969;76(1):175-178
76. Delgado y Garnia R, Chavez-Esgueda JM. Etofamide in the treatment of children with acute intestinal amebiasis [Etofamida en el tratamiento de ninos con amibiasis intestinal aguda]. Prensa Medica Mexicana 1971;36(7-8):358-361
77. Devic J, Dosen H. Our initial experiences in the treatment of the intestinal amebiasis with 2-dehydroemetine. Medicinski Pregled 1974; 27(1-2):79-83.
78. Dhariwal RK,Verma NP,Nioguy C, Pal SK, Singh SS,Chatterjee AK, et al.Clinical trial with entamide furoate in acute amebic dysentery. Indian Journal of Medical Science 1963;17:825-826
79. Donckaster R, Sapunar J, Donoso A. Treatment of chronic intestinal amebiasis with tetracycline and chloroquine with bismuth glycoarsanilate and parasitological control by the combined telemann and polvinyl alcohol method [Ensayo terapeutico de la amibiasis intestinal cronica con tetraciclina y chloroquina glicolilarsanilato de bismuto y control parasitologico con losmetodos de telemann y alcohol polivinilico combinados]. Boletin Chileno de Parasitologia 1957; 12(2):24-29
80. dos Santos Moraise ML. Clinico-pathological results using erythromycin stearate in the treatment of intestianl amebiasis [Resultados clinico-parasitologicos obtidos com o uso do estearato de eritromicina de liberacao regulada no tratamento da amebiase intestinal]. Hospital (Rio de Janeiro, Brazil) 1969;75(4):1367-1374
81. Doshi JC,Doshi MJ, Vaidya AB,Mehta JM, Sheth UK.Niridazole in amebic dysentery and hepatic amebiasis. American Journal of Tropical Medicine and Hygiene 1968;17(5):702-708
82. el Mofti A, Ayadi A. Trial of a new amoebicidal agent (choro-hydroxyquinoline). Journal of the Egyptian Medical Association 1965;48(2): 142-146
83. Esquivel Lopez A,Gonzales Espinola G,Garcia Garduno JR,Guarner Dalias V. Various considerations in the treatment of amoebic liver abscess [Algunas consideraciones en el tratamiento del absceso hepatico amibiano]. Revista De Gastroenterologia De Mexico 1979;44(2): 51-56
84. Ey JL. Treatment of amoebiasis with metronidazole and entamide furoate. Ethiopian Medical Journal 1977;15:101-105 (Pubitemid 8324369)
85. * Felix H, Freyria J, Maillard A. 2-dehydro-emetine administered per os in the treatment of amoebiasis. Therapeutical tests [La 2-dehydro-emetine administree par voie orale dans le traitement de l'amibiase. Essais therapeutiques]. Le Journal de Medecine de Lyon 1966;47(104):1211-1216
86. Felix H, Freyria J, Maillard A. Recent developments. 2-dehydroemetine administered orally in the treatment of amoebiasis. Therapeutic trials (50 personal cases) [La 2-dehydro-emetine administree par voie orale dans le traitement de l'amibiase. Essais therapeutiques (a propos de 50 cas personnels)]. Archives Francaises des Maladies de l'Appareil Digestif 1966;55(10):909-914
87. Freeman O, Akamaguna A, Jarikre LN. Amoebic liver abscess: the effect of aspiration on the resolution or healing time. Annals of Tropical Medicine and Parasitology 1990;84(3):281-287 (Pubitemid 20323518)
88. Gilman R, Islam M, Paschi S, Goleburn J, Ahmad F. Comparison of conventional and immunofluorescent techniques for the detection of Entamoeba histolytica in rectal biopsies. Gastroenterology 1980; 78(3):435-439 (Pubitemid 10150479)
89. Gorbea Robles MC, Eternod JG, Velasquez FG, Cupido JD. Comparative study in intestinal amebiasis and giardasis in infants and preschool: efficacy and tolerance of secnidazole vs metronidazole and etofamide [Estudio comparativo en amebiasis y giardiasis intestinal del lactante y pre-escolar: eficacia y tolerancia del secnidazole vs metronidazol y etofamida]. Investigacion Medicina Inst 1989;16:79-82.
90. Hatchuel W. Tinidazole for the treatment of amoebic liver abscess. South African Medical Journal 1975;49(45):1879-1881
91. Hoekenga MT. A comparison of aureomycin and carbarsone in the treatment of intestinal amebiasis. American Journal of Tropical Medicine and Hygiene 1951;31(4):423-425
92. Holz J. Comparison of natural and synthetical emetine as amebicide in children. Paediatrica Indonesiana 1965;5(3):793-801.
93. Huggins D. Treatment of amebiasis. Results obtained with diloxanide furoate [Tratamento da amebiase. Resultados obtidos com o furoato de diloxanida]. Revista do Instituto de Medicina Tropical de São Paulo 1965;7(2):110-111
94. Huggins D. Clinical trial of a new salt: ethyl chordiphene, in the treatment of chronic intestinal amebiasis [Ensaio clinico com um novo sal: etil clordifene, no tratamento da amebiase intestinal cronica]. Anais da Escola Nacional de Saude Publica e de Medicina Tropical 1969;3(1):93-95
95. Huggins D. Chemoprophylaxis of amebiasis: clinical trial with a new drug etophamide, in an open community [Quimoprofilaxia da amebiase, ensaio clinico com uma nova substancia-etofamida, em uma comunidade aberta]. Anais do Instituto de Higiene e Medicina Tropical 1974;2(1-4):545-551
96. * Huggins D. Clinical and chemoprophilatical trial with a new drug used against amebiasis in an open community [Ensaio clinico e quimoprofilatico com etofamida, uma substancia amebicida numa comunidade aberta]. Revista Brasiliera de Clinica e Terapeutica 1974; 3(7):279-284
97. Huggins D. Clinical test with teclozan in the treatment of amebic dysentery with a dose of 24 hours [Ensaio clinico com teclozan no tratamento da colite amebiana nao desinterica na dose de 24 horas]. Anais do Instituto de Higiene e Medicina Tropical 1977-1978;5(1-4): 329-331
98. Huggins D. Clinical trial of etophamide in the treatment of chronic intestinal amebiasis. G.E.N 1980;34(1):51-54 (Pubitemid 11165890)
99. Huggins D. Clinical trials with RO 7-0207, ornidazole, in the treatment of chronic intestinal amebiasis [Ensaio clinico comRo 7-0207, ornidazol, no tratamento da amebiase intestinal cronica]. Folha Medica 1981;82(4):445-446
100. Irusen EM, Jackson TF, Simjee AE. Asymptomatic intestinal colonization by pathogenic Entamoeba histolytica in amebic liver abscess: prevalence, response to therapy, and pathogenic potential. Clinical Infectious Diseases 1992;14(4):889-893
101. Islam N, Hasan M. Tinidazole in the treatment of intestinal amoebiasis. Current Therapeutic Research 1975;17(2):161-165
102. Islam N, Hasan K. Tinidazole and metronidazole in hepatic amoebiasis. Drugs 1978;15 Suppl 1:26-29 (Pubitemid 8341320)
103. Islam N, Hasan M. Tinidazole and metronidazole in hepatic amoebiasis. Journal of Tropical Medicine and Hygiene 1978;81(1):20-22
104. Jain NK, Madan A, Sharma TN, Sharma DK,Mandhana RG. Hepatopulmonary amoebiasis. Efficacy of various treatment regimens containing dehydroemetine and/or metronidazole. Journal of the Association of Physicians of India 1990;38(4):269-271
105. Jayawickrema US, Lionel ND. Comparison of metronidazole with emetine and chloroquine in the treatment of hepatic amoebiasis - a controlled double blind study. Ceylon Medical Journal 1975;20(2): 99-102.
106. Kaur J, Mathur TN. Comparative drug trials in symptomatic and asymptomatic non-dysenteric amoebic colitis. Indian Journal of Medical Research 1972;60(10):1547-1553
107. Khalil HM, Fawzy AF, Sarwat MA. Trials of furazol and some other drugs in intestinal amoebiasis. Journal of the Egyptian Society of Parasitology 1987;17(2):417-425
108. Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Comparative study of tinidazole and metronidazole in amoebic liver abscess. Current Medical Research and Opinion 1977;5 (2):161-163 (Pubitemid 8225644)
109. Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs 1978;15 Suppl 1:23-25
110. Konar NR,Mandal AK. Clinical trial of dehydroemetine in amoebiasis. Journal of the Indian Medical Association 1963;41(11):529-534
111. Krishnaiah YSR, Muzib YI, Bhaskar P, Satyanarayana V, Latha K. Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of tinidazole in healthy human volunteers. Drug Delivery 2003;10(4):263-268 (Pubitemid 37494140)
112. Kurt O, Girginkardesler N, Balcioglu IC, Ozbilgin A, Ok UZ. A comparison ofmetronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clinical Microbiology and Infections 2008; 14:601-604 (Pubitemid 351639076)
113. Laham E. Clinical trial of bismuth glycolyl arsenilate in intestinal amebiasis [Essai clinique du glycolyl arsenilate de bismuth dans l'amibiase intestinale]. Revue Medicale du Moyen-Orient 1951;8(1): 96-99
114. Levy A,Martinez AA, de Castro ML. Sustained release erythromycin stearate in the therapy of intestinal amebiasis [Estearatao de eritromicina de liberacao regulada no tratamento da amebiase intestinal]. Revista Brasileira de Medicina 1967;24(6):413-415
115. Martinez AA, Levy A. Efficiency of the combination erythromycinhexocylium in the treatment of dysentery syndromes [Eficacia da associacao eritromicina-hexociclio no tratamento de sindromes disentericas]. Revista Brasileira de Medicina 1969;26(12):759-762
116. Masters DK, Hopkins AD. Therapeutic trials of four amoebicide regimens in rural Zaire. Journal of Tropical Medicine and Hygiene 1979;82(5):99-101.
117. Mathur TN, Kaur J.Non-dysenteric amoebic colitis treated with two grammes ofmetronidazole given as a single dose for two days. Indian Journal of Medical Research 1974;62(8):1208-1211
118. McAuley JB, Juranek DD. Paromomycin in the treatment of mild-to-moderate intestinal amebiasis. Clinical Infectious Diseases 1992; 15(3):551-552
119. Mendis S, Dharmasena BD, Jayatissa SK. Comparison of tinidazole with metronidazole in the treatment of hepatic amoebiasis: a controlled double blind study. Ceylon Medical Journal 1984;29(2):97-100.
120. Misra NP, Laiq SM. Tinidazole in intestinal amoebiasis. Antiseptic 1976;73(7):371-373
121. Misra NP, Laiq SM. Tinidazole in intestinal amoebiasis. Journal of the Association of Physicians of India 1976;24(4):231-235
122. Morales-Mareles P, Suarez-Sanchez F, Boom RA. Random double blind comparison of intravenous metronidazole and intramuscular emetine in acute amebic liver abscess [Tratamiento doble ciego al azar con metronidazole i.v. o emetina i.m. en el absceso hepatico amibiano agudo]. Prensa Medica Mexicana 1975;40(3-4):124-126
123. Murray MJ, Murray A, Murray CJ. The salutary effect of milk on amoebiasis and its reversal by iron. British Medical Journal 1980;280 (6228):1351-1352 (Pubitemid 10124275)
124. Muzaffar J, Madan K, Sharma MP, Kar P. Randomized, singleblind, placebo-controlled multicenter trial to compare the efficacy and safety of metronidazole and satranidazole in patients with amebic liver abscess. Digestive Disease Science 2006;51(12):2270-2273
125. Nahrevanian H, Assmar M. Cryptosporidiosis in immunocompromised patients in the Islamic Republic of Iran. Journal of Microbiology Immunology and Infection 2008;41:74-77 (Pubitemid 351792125)
126. Naik BK, Saboo RM.Quixalin. A drug trial. Journal of the Association of Physicians of India 1968;16(5):313-316
127. Nanavati MB, Damany SJ, Joshi HD.Clinical trial of deydroemetine (Ro 1-9334) in amoebiasis. Indian Practitioner 1965;18:259-263
128. Nel JR, Patel A, Ramidal K, Simjee AE, Englebrecht HE, Dingle C, et al.Does aspiration influence the course of amoebic liver abscess? [abstract]. South African Medical Journal 1985:68528.
129. Nel JD, Simjee AE, Patel A. Indications for aspiration of amoebic liver abscess (ALA) [abstract]. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde 1986:7050.
130. O'Holohan DR, Hugoe-Matthews JH. Single-dose and short course regimens of metronidazole in the treatment of amoebiasis in Malaysia. Annals of Tropical Medicine and Parasitology 1972;66(2):181-186
131. Okeniyi JA, Ogunlesi T A, Oyelami OA, Adeyemi L A. Effectiveness of dried Carica papaya seeds against human intestinal parasitosis: a pilot study. Journal of Medicine and Food 2007;10(1):194-196
132. Olaeta Elizalde R, Perez Huacuja R, Najera Ruano A. Comparison of quinfamide versus etofamide in the Mexican population with intestinal amebiasis [Comparacion quinfamida vs etofamida en poblacion Mexicana con amibiasis intestinal]. Acta Gastroenterologica Latino americana 1996;26(5):277-280
133. Omrani G, Rastegar-Lari A, Khamse M. Effect of single dose of secnidazole in treatment of intestinal amoebiasis. Journal of the Pakistan Medical Association 1995;45(6):159.
134. Orozco Garcia O, Perez Nava J,Gonzalez Diaz R.Clinical evaluation of nimorazole in amebic liver abscess (author's transl)]. Prensa Medica Mexicana 1975;40(11-12):378-382
135. Padilla N, Figueroa R, Rivera MR,Guerrero S. Comparative study in quinfamide and etofamide in the treatment of asymptomatic amoebic infection [Estudio comparativo entre quinfamida y etofamida en el tratamiento de lainfección amibiana asintomática]. Revista Mexicana de Pediatría 1995;62(1):5-7.
136. Padilla-Raygoza N, Alarcon-Ginori A, Figueroa-Ferrari RC,Munoz-Rodriguez M. Comparison of the effect of quinfamide and nitazoxanide in the treatment of nondysenteric intestinal amebiasis in children [Comparacion del efecto de la quinfamida y de la nitazoxanida en el tratamento de la amibiasis intestinal no disenterica en ninos]. Revista Mexicana de Pediatria 1998;65(5):196-199
137. Padilla N, Diaz R, Alarcon A, Barreda R. Antiamoebic chemoprophylaxis using quinfamide in children: a comparative study. Scientific World Journal 2002;2:1070-1078
138. Pimparkar BD, Raghavan P, Satoskar RS. A clinical trial of 1-dichloroacetyl-4-methylpiperidine (R.D. 7098) a new anti-amoebic drug. Transactions of the Royal Society of Tropical Medicine and Hygiene 1966;60(2):237-240
139. Populaire P, Decouvelaere B, Renard A, Pasquier P. Study of seric concentrations and urinary excretion of secnidazole after oral administration in man. Comparison with tinidazole [Etude des taux seriques et de l'elimination urinaire du secnidazole apres adminsitration orale chez l'homme comparaison avec le tinidazole]. Pathologie et Biologie 1980;28(9):621-624
140. Powell SJ,MacLeod I,Wilmot AJ, Elsdon-Dew R. The treatment of acute amoebic dysentery: trials of dehydroemetine, of dehydroemetine-bismuth-iodide, and of dehydroemetine and dehydroemetinebismuth-iodide in combination. Annals of Tropical Medicine and Parasitology 1965;59:205-207
141. Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R. A comparative trial of dehydroemetine, emetine hydrochloride and chloroquine in the treatment of amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1965;59(4):496-499
142. Powell SJ,Wilmot AJ,Macleod IN, Elsdon-Dew R. Dehydroemetine in the treatment of amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1965;59(2):208-209
143. Powell SJ,MacLeod I,Wilmot AJ, Elsdon-Dew R. Further drug trials in acute amoebic dysentery: demethylchlortetracycline, methacycline, ampicilllin and chlorhydroxyquinoline. Transactions of the Royal Society of Tropical Medicine and Hygiene 1965;59(6):709-711
144. Powell SJ,MacLeod I,Wilmot AJ,Elsdon-Dew R.Ambilhar in amoebic dysentery and amoebic liver abscess. Lancet 1966;i:20-22
145. Powell SJ, MacLeod I, Wilmot AJ, Elsdon-Dew R. Late release oral dehydroemetine in acute amoebic dysentery. Journal of Tropical Medicine and Hygiene 1966;69:153-154
146. Powell SJ, Wilmot AJ, MacLeod I, Elsdon-Dew R. The effect of a nitro-thiazole dericative, Ciba 32,644-Ba, in amebic dysentery and amebic liver abscess. American Journal of Tropical Medicine and Hygiene 1966;15(3):300-302
147. Powell SJ, Wilmot AJ, Macleod IN, Elsdon-Dew R. A comparative trial of dehydroemetine and emetine hydrochloride in identical dosage in amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1967;61(1):26-28
148. Powell SJ. Metronidazole in the treatment of amoebic dysentery. Indian Practitioner 1968:696-700.
149. Powell SJ, Wilmot AJ, Elsdon-Dew R. Single and low dosage regimens of metronidazole in amoebic dysentery and amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1969;63(2):139-142
150. Powell SJ, Wilmot AJ, Elsdon-Dew R. The use of niridazole alone and in combination with other amoebicides in amoebic dysentery and amoebic liver abscess. Annals of the New York Academy of Science 1969;160(2):749-754
151. Powell SJ. Drug trials in amoebiasis. Bulletin of the World Health Organization 1969;40(6):956-958
152. Powell SJ, Elsdon-Dew R. Evaluation of metronidazole and MK910 in invasive amebiasis. American Journal of Tropical Medicine and Hygiene 1971;20(6):839-841
153. Powell SJ, Elsdon-Dew R. Chloroquine in amoebic dysentery. Transactions of the Royal Society of Tropical Medicine and Hygiene 1971;65 (4):540.
154. Powell SJ, Elsdon-Dew R. Some new nitroimidazole derivatives. Clinical trials in amebic liver abscess. American Journal of Tropical Medicine and Hygiene 1972;21(5):518-520
155. Powell SJ. Latest developments in the treatment of amebiasis. Advances in Pharmacology and Chemotherapy 1972;10:91-103.
156. Powell SJ, Rubidge CJ, Elsdon-Dew R. Clinical trials of benzoyl metronidazole suspension in amoebic dysentery and amoebic liver abscess. South African Medical Journal 1973;47(12):507-508
157. Prakash C, Bansal BC, Bansal MR. A comparative study of tinidazole and metronidazole in symptomatic intestinal amoebiasis. Journal of the Association of Physicians of India 1974;22(7):527-529
158. Qureshi H, Baqai B, Zuberi SJ, Ahmed W, Qureshi SA. Efficacy of secnidazole in the treatment of intestinal amoebiasis. Journal of the Pakistan Medical Association 1994;44(4):93-94 (Pubitemid 24147493)
159. Qureshi H, Ali A, Baqai R, Ahmed A. Efficacy of a combined diloxanide furoate-metronidazole preparation in the treatment of amoebiasis and giardiasis. Journal of International Medical Research 1997; 25(3):167-170 (Pubitemid 27241343)
160. Rodrigues LD, Jafferian PA, Villela Mde P, de Mello EB.Comparative study on 3 amebicides: teclozine, clefamide and a combination of clefamide and iodo-chloro-oxyquinolines and streptomycin [Estudo comparativo de tres amebicidas: o teclozine, a clefamida e a associacao de clefamida com iodo-cloro-oxiquinoleina e estreptomicina]. Hospital (Rio de Janeiro, Brazil) 1968;74(5):1563-1573
161. Ruas A,Correia MH, Valle JC do, Ribeiro JA. RO7-0207 in amoebic liver abscess. Comparative study of the effects of RO 7-0207 and metronidazole. Central African Journal of Medicine 1973;19(6):128-132
162. Ruchko AF. Clinical and treatment characteristics of amebiasis in children in a hot climate. Pediatriia, Akusherstvo i Ginekologiia 1978, (5):28-29
163. Saha TK,Chaudhuri RN.Clinical trial of furoxone in amoebic dysentery. Bulletin of the Calcutta School of Tropical Medicine 1966;14(1): 22.
164. Saha TK, Mandal JN. Niridazole in amoebic dysentery. Journal of the Indian Medical Association 1970;55(4):127-129
165. Salem HH, Rabbo HA. Clinical trials with dehydroemetine dihydrochloride in the treatment of acute amoebiasis. Journal of Tropical Medicine and Hygiene 1964;67:137-141
166. Salem SN. Clinical trial of oral dehydroemetine in intestinal amoebiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61(6):774-775
167. Sandia OG,Dobbins Filho J, Leite IC,Harris PB. Comparative therapeutic trial of ornidazole and metronidazole in chronic amebiasis [Ensaio terapeutico comparativo entre ornidazole e metronidazol em amebiase cronica]. Revista do Instituto de Medicina Tropical de São Paulo 1977;19(1):52-56
168. Sangiuolo F. Antimicrobial and antispastic effect of a combination of canulase and iodochloroxyquinoline (Septo-canulase) in various acute and chronic enteropathies [Sull'azione antimicrobica ed antispastica di una associazione di canulase con iodoclorossichinolina (Septo-canulase) in alcune enteropatie acute e croniche]. Rassegna Internazionale di Clinica e Terapia 1969;49(19):1231-1250
169. Sankale M, Moulanier M. Treatment of amebiasis with oral dehydroemetine [Le traitement de l'amibiase par la dehydroemetine orale]. Therapie 1966;21(3):733-741
170. Sankale M, Satge P, Lariviere M, Moulanier M, Bourgeade A, Debroise C, et al.Efficacy of niridazole in amoebic dysentery. Annals of the New York Academy of Science 1969;160(2):755-763
171. Sankale M, Coly D, Niang I. Treatment of amoebiasis with a drinkable suspension of metronidazole [Traitement de l'amibiase par une suspension buvable de metronidazole]. Therapie 1974;29:411-415
172. Satpathy BK, Acharya SK, Satpathy S. Comparative study of intravenous metronidazole and intramuscular dehydroemetine in amoebic liver abscess. Journal of the Indian Medical Association 1988;86 (2):38-40. (Pubitemid 18137956)
173. Schapiro MM. Intestinal amebiasis. A preliminary clinical trial of furamide T/c. American Journal of Tropical Medicine and Hygiene 1967;16(6):704-707
174. Scragg JN, Powell SJ. Emetine hydrochloride and dehydroemetine combined with chloroquine in the treatment of children with amoebic liver abscess. Archives of Disease in Childhood 1968;43(227):121-123
175. Scragg JN, Powell SJ. Metronidazole and niridazole combined with dehydroemetine in treatment of children with amoebic liver abscess. Archives of Disease in Childhood 1970;45(240):193-195
176. Segal J. Clinico-paracytological and therapeutic study with a new preparation of erythromycin stearate of controlled release (A-16535) [Estudo clinico-parasitologico e terapeutico com uma nova preparacao de estearato de eritromicina de liberacao regulada (A-16535)]. Revista Brasileira de Medicina 1967;24(8):626-632
177. Sharma MP, Rai RR, Acharya SK, Ray JC, Tandon BN. Needle aspiration of amoebic liver abscess. BMJ 1989;299(6711):1308-1309 (Pubitemid 20002266)
178. Shrotriya V, Dabral SB, Maheshwari BB, Gupta SC, Maheshwari BB. A controlled trial of Diarex and tinidazole in chronic intestinal amoebiasis. Medicine and Surgery 1985;25(1):8-9,16. (Pubitemid 15055109)
179. Simjee AE, Gathiram V, Jackson TF, Khan BF. A comparative trial of metronidazole v. tinidazole in the treatment of amoebic liver abscess. South African Medical Journal. Suid-Afrikaanse Tydskrif Vir Geneeskunde 1985;68(13):923-924 (Pubitemid 16178834)
180. Simon M, Shookhoff HB, Terner H,Weingarten B, Parker JG. Paromomycin in the treatment of intestinal amebiasis; a short course of therapy. American Journal of Gastroenterology 1967;48(6):504-511
181. Sinuhaji AB, Lubis CP, Daulay HRM, Lubis IT, Jufri A, Sutanto AH. A double-blind trial between metronidazole and secnidazole in acute amebic dysetnery in children (Preliminary Report). Paediatrica Indonesiana 1986;26:9-14.
182. Sladden DL, Taylor E, Livingstone DJ. A clinical trial of a new compound (dehydroemetine bismuth iodide, Ro 4,3076) in amoebic dysentery. The Central African Journal of Medicine 1964;10(11): 412-413
183. Soh CT, Cho MJ, Choi HJ,Hur JD. Double blind test of ornidazole versus tinidazole against amoebic liver abscess. Yonsei Reports on Tropical Medicine 1980;11(1):43-50.
184. Spellberg MA. Treatment of amoebic liver abscess. American Journal of Gastroenterology 1969;51(4):298-302.
185. Spillman R, Ayala SC, Sanchez CE. Double blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers. American Journal of Tropical Medicine and Hygiene 1976;25(4):549-551
186. Sutrisno D, Ismail D, Sebodo T, Ismangun, Noerhajati S. Nitrimidazine (Naxogin) in the treatment of children with intestinal amoebiasis. Paediatrica Indonesiana 1978;18(7-8):217-223
187. Tandon A, Jain AK,Dixit VK, Agarwal AK,Gupta JP.Needle aspiration in large amoebic liver abscess. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 1997;18(1):19-21.
188. Thoren K, Hakansson C, Bergstrom T, Johnaisson G, Norkrans G. Treatment of asymptomatic amebiasis in homosexual men. Clinical trials withmetronidazole, tinidazole, and diloxanide furoate. Sexually Transmitted Diseases 1990;17(2):72-74 (Pubitemid 20224327)
189. Thoren K, Hakansson C, Bergstrom T, Johnaisson G, Norkrans G. Treatment of asymptomatic amoebiasis in homosexual men: clinical trials with metronidazole, tinidazole and diloxanide furoate [abstract]. Genitourinary Medicine 1990;66(5):411.
190. Tjaij JK, Raid N, Irawati T, Siregar D, Kwo IT, Tan BE. Mexaform and entobex therapy in amebic dysentery. Paediatrica Indonesiana 1969;9(5):210-214
191. Tjaij JK, Raid N, Sutanto AH.Clinical trials of oral dehydro-emetine tablets (Ro 1-9334/10) in amebic dysentery in children. Paediatrica Indonesiana 1970;10(4):139-148
192. Vaidya AB, Ray DK,Mankodi NA, Paul T, Sheth UK. Phase I tolerability and antiamoebic activity studies with 1-methylsulphonyl-3-(1-methyl-5-nitro-2- imidazolyl)-2-imidazolidinone (Go 10213): a new antiprotozoal agent. British Journal of Clinical Pharmacology 1983; 16(5):517-522
193. Vakil BJ, Shah SC,Moses JM. The comparative value of dehydroemetine and emetine in amebiasis. Journal of the Association of Physicians of India 1967;15(5):223-228
194. Vakil BJ, Dalal AJ, Mehta AJ, Mody NC. Clinical evaluation of oral dehydroemetine in amoebiasis. Journal of the Association of Physicians of India 1971;19(5):403-408
195. Vakil BJ, Dalal NJ. Comparative evaluation of amoebicidal drugs. Progress in Drug Research 1974;18:353-364
196. Valencia-Parparcen J. Erythromycin in the treatment of intestinal amebiasis and other processes of the digestive tract [La eritromicina en el tratamiento de la amibiasis intestinal y otros procesos del tubo digestivo]. G.E.N 1973;28(1):29-37.
197. Vanijanonta S, Bunnag D, Looareesuwan S, Harinasuta T. Low dose tinidazole in the treatment of amoebic liver abscess. Southeast Asia Journal of Tropical Medicine and Public Health 1985;16(2):253-256 (Pubitemid 16226885)
198. Viswanathan M, Krishnaswami CV. Therapeutic trials with oral dehydroemetine in intestinal amoebiasis. Journal of the Indian Medical Association 1968;51(8):381-383
199. Wang LT, Sung JL. Trials of metronidazole in amebic dysentery and amebic liver abscess. Taiwan Yi Xue Hue Za Zhi 1971;70(7):405-408
200. Wang LT, Yang SP. Studies on oxytetracycline resistant amebic dysentery. Taiwan Yi Xue Hue Za Zhi 1971;70(3):131-134
201. Watson PG. Amoebic infection of the eye. Transactions of the Ophthalmological Societies of the United Kingdom 1975;95(2):204-206
202. Welch JS, Rowsell BJ, Freeman C. Treatment of intestinal amoebiasis and giardiasis. Efficacy of metronidazole and tinidazole compared. Medical Journal of Australia 1978;1(9):469-471 (Pubitemid 8405768)
203. Widjaya P, Bilic A, Babic Z, Ljubicic N, Bakula B, Pilas V. Amoebic liver abscess: ultrasonographic characteristics and results of different therapeutic approaches. Acta Medica Iugoslavica 1991;45(1):15-21.
204. Wilmot AJ, Powell SJ, MacLeod I, Elsdon-Dew R. Paromomycin in acute amoebic dysentery. Annals of Tropical Medicine and Parasitology 1962;56:383-386
205. Wolfe MS. Nondysenteric intestinal amoebiasis. JAMA 1973;224 (12):1601-1604
206. Wolfensberger HR. Amoebiasis: clinical trials of dehydroemetine late-release tablets (Ro 1-9334/20) compared with parenteral dehydroemetine and niridazole. Transactions of the Royal Society of Tropical Medicine and Hygiene 1968;62(6):831-837
207. Zuberi SJ, Ibrahim M. Tinidazole in amoebiasis. Practitioner 1973; 211:93-95
208. Guevara L. Evaluation of the tolerance and efficiency of quinfamide, a new intraluminal amebicide, in man (one day treatment). Double blind study. Revista de Gastroenterologia de Mexico 1980;45(2):93-97
209. Soedin K, Lelo A. A single dose of secnidazole vs a 5-day regimen of the combination tetracycline/clioquinol in the treatment of intestinal ameobiasis. Proceedings of the 16th International Congress of Chemotherapy; 1989 Jun 12; Jerusalem, Israel. Amsterdam: Excerpta Medica, 1989:43-48
210. American Academy of Pediatrics. Amebiasis. In: Pickering LK, Baker CJ, Long SS, McMillan JA, et al. editor(s). Red Book: 2006 Report of the Committee on Infectious Diseases. 27th Edition. Elk Grove Village, IL: American Academy of Pediatrics, 2006:204-206
211. Abd-Alla MD, Ravdin JI. Diagnosis of amoebic colitis by antigen capture ELISA in patients presenting with acute diarrhoea in Cairo, Egypt. Tropical Medicine and International Health 2002;7(4):365-370
212. Adams EB, MacLeod IN. Invasive amebiasis. I. Amebic dysentery and its complications. Medicine 1977;56(4):315-323 (Pubitemid 8130614)
213. Barwick RS,Uzicanin A, Lareau S,Malakmadze N, Imnadze P, Iosava M, et al.Outbreak of amebiasis in Tbilisi, Republic of Georgia, 1998. American Journal of Tropical Medicine and Hygiene 2002;67(6):623-631 (Pubitemid 36014919)
214. Blessman J, Ali IKM, Ton Nu PA,Dinh BT,Ngo Viet TQ, Van AL, et al.Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers. Journal of Clinical Microbiology 2003; 41(10):4745-4750
215. Braga LL, Lima AAM, Sears CL, Newman RD,Wuhib T, Paiva CA, et al.Seroepidemiology of Entamoeba histolytica in a slum in Northeastern Brazil. American Journal of Tropical Medicine and Hygiene 1996;55(6):693-697 (Pubitemid 27111009)
216. Braga LL, Mendonca Y, Paiva CA, Sales A, Cavalcante ALM, Mann BJ. Seropositivity for and intestinal colonization with Entamoeba histolytica and Entamoeba dispar in individuals in Northeastern Brazil. Journal of Clinical Microbiology 1998;36(10):3044-3045 (Pubitemid 28429435)
217. Brooks JL, Kozarek RM. Amebic colitis. Preventing morbidity and mortality from fulminant disease. Postgraduate Medicine 1985;78 (1):267-274
218. Chen HT, Hsu YH, Chang YZ. Fulminant amebic colitis: recommended treatment to improve survival. Tzu Chi Medical Journal 2004;16:1-8.
219. Dans L,Martinez E. Amoebic dysentery. Clinical Evidence 2006;15: 1007-1013
220. Ellyson JH, Bezmalinovic Z, Parks SN, Lewis FR Jr. Necrotizing amebic colitis: a frequently fatal complication. American Journal of Surgery 1986;152(1):21-26 (Pubitemid 16069549)
221. Gathiram V, Jackson TF. Frequency distribution of Entamoeba histolytica zymodemes in a rural South African population. Lancet 1985;1:719-721 (Pubitemid 15104949)
222. Gathiram V, Jackson TFHG. A longitudinal study of asymptomatic carriers of pathogenic zymodemes of Entamoeba histolytica. South African Medical Journal 1987;72:669-672 (Pubitemid 18086508)
223. Gatti S, Swierczynski G, Robinson F, Anselmi M, Corrales J, Moreira J, et al.Amebic infections due to the Entamoeba histolytica-Entamoeba dispar complex: a study of the incidence in a remote rural area of Ecuador. American Journal of Tropical Medicine and Hygiene 2002;67(1):123-127 (Pubitemid 35034332)
224. Gonzalez-Ruiz A, Haque R, Aguirre A, Castanon G, Hall A, Guhl F, et al.Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica. Journal of Clinical Pathology 1994;47(3):236-239 (Pubitemid 24120686)
225. Haque R, Neville LM, Hahn P, Petri WA Jr. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entameoba histolytica stool antigen detection kits. Journal of Clinical Microbiology 1995; 33(10):2558-2561
226. Haque R, Faruque ASG, Hahn P, Lyerly DM, Petri WA Jr. Entamoeba histolytica and Entamoeba dispar infection in children in Bangladesh. Journal of Infectious Diseases 1997;175(3):734-736 (Pubitemid 27086189)
227. Haque R, Ali IKM, Akther S, Petri WA Jr. Comparison of PCR, isoenzyme analysis, and antigen detection for diagnosis of Entamoeba histolytica infection. Journal of Clinical Microbiology 1998;36(2): 449-452 (Pubitemid 28060310)
228. Haque R, Ali IM, Petri WA Jr. Prevalence and immune response to Entamoeba histolytica infection in preschool children in Bangladesh. American Journal of Tropical Medicine and Hygiene 1999;60(6):1031-1034 (Pubitemid 29296232)
229. Haque R, Ali IM, Sack RB, Farr BM, Ramakrishnan G, Petri WA Jr. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. Journal of Infectious Diseases 2001;183(12):1787-1793 (Pubitemid 32523242)
230. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, et al.Innate and acquired resistance to amebiasis in Bangladeshi children. Journal of Infectious Diseases 2002;186(4):547-552 (Pubitemid 34876265)
231. Haque R,Huston CD,Hughes M,Houpt E, Petri WA Jr. Amebiasis. New England Journal of Medicine 2003;348(16):1565-1573
232. Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM, et al.Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infection and Immunity 2006;74(2):904-909 (Pubitemid 43185523)
233. Higgins JPT, Green S, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Appendix 5b www.cochrane.org/resources/handbook/hbook.htm (accessed 31 May 2005).
234. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. Higgins JPT,Green S (editors), Cochrane Handbook of Systematic Reviews of Interventions. Chichester: John Wiley & Sons, 2008.
235. Hutchinson D. The trial investigator's GCP handbook: A practical guide to ICH requirements. Brookwood: Brookwood Medical Publications, 1997.
236. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323 (7303):42-46 (Pubitemid 32682008)
237. Knight R. The chemotherapy of amoebiasis. Journal of Antimicrobial Chemotherapy 1980;6(5):577-593
238. Li E, Stanley SL Jr. Parasitic diseases of the liver and intestines. Gastroenterology Clinics 1996;25(3):471-492
239. Looke DFM. Metronidazole and tinidazole compared. Australian Prescriber 1987;10(2):35-37
240. The Medical Letter. Drugs for parasitic infections. www.medletter.com 2004 (accessed 1 March 2005):1-12.
241. Mondal D, Petri WA, Sack RB, Kirkpatrick BD, Haque R. Entamoeba histolytica-associated diarrheal illness is negatively associated with the growth of preschool children: evidence from a prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 2006;100(11):1032-1038 (Pubitemid 44321342)
242. Monro AM. Blood levels of chemotherapeutic drugs and the pharmacokinetics of tinidazole and metronidazole. Current Medical Research and Opinion 1974;2(3):130-136
243. Nesbitt RA, Mosha FW, Katki HA, Ashraf M, Assenga C, Lee CM. Amebiasis and comparison of microscopy to ELISA technique in detection of Entamoeba histolytica and Entamoeba dispar. Journal of the National Medical Association 2004;96(5):671-677 (Pubitemid 38560914)
244. Patterson M, Schoppe LE. The presentation of amebiasis. Medical Clinics of North America 1982;66(3):689-705.
245. Pelaez M, Villazon A, Sieres Zaraboso R. Amebic perforation of the colon. Diseases of the Colon and Rectum 1966;9(5):356-362
246. Petri WA Jr, Singh U.Diagnosis andmanagement of amebiasis. Clinical Infectious Diseases 1999;29(5):1117-1125
247. Petri WA Jr, Haque R, Lyerly D, Vines RR. Estimating the impact of amebiasis on health. Parasitology Today 2000;16(8):320-321
248. Powell SJ,MacLeod I,Wilmot AJ, Elsdon-Dew R.Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet 1966;2(7477): 1329-1331
249. Powell SJ. Short-term follow-up studies in amoebic dysentery. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61 (6):765-768
250. Powell SJ,Wilmot AJ, Elsdon-Dew R. Further trials ofmetronidazole in amoebic dysentery and amoebic liver abscess. Annals of Tropical Medicine and Parasitology 1967;61(4):511-514
251. Powell SJ. Drug therapy of amoebiasis. Bulletin of the World Health Organization 1969;40(6):953-956
252. Powell SJ. New developments in the therapy of amoebiasis. Gut 1970;11(11):967-969
253. Ramos F, Moran P, Gonzalez E, Garcia G, Ramiro M, Gomez A, et al.High prevalence rate of Entamoeba histolytica asymptomatic infection in a rural Mexican community. American Journal of Tropical Medicine and Hygiene 2005;73(1):87-91. (Pubitemid 41278754)
254. Ravdin JI. Entamoeba histolytica (Amebiasis). In: Mandell GL, Bennett JE, Dolin R editor(s). Principles and oractice of infectious diseases. 6th Edition. Philadelphia: Churchill Livingstone, 2005: 3097-3111
255. Reed SL. Amebiasis: an update. Clinical Infectious Diseases 1992;14 (2):385-393
256. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
257. Rivera WL, Tachibana H, Kanbara H. Field study on the distribution of Entamoeba histolytica and Entamoeba dispar in the Northern Philippines as detected by the polymerase chain reaction. American Journal of Tropical Medicine and Hygiene 1998;59(6):916-921 (Pubitemid 29028922)
258. Rivera WL, Santos SR, Kanbara H. Prevalence and genetic diversity of Entamoeba histolytica in an institution for the mentally retarded in the Philippines. Parasitology Research 2006;98:106-110 (Pubitemid 41797999)
259. Samarawickrema NA, Brown DM, Upcroft JA, Thammapalerd N, Upcroft P. Involvement of superoxide dismutase and pyruvate: ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. Journal of Antimicrobial Chemotherapy 1997; 40(6):833-840 (Pubitemid 28022148)
260. Samie A, Obi LC, Bessong PO, Stroup S, Houpt E, Guerrant RL. Prevalence and species distribution of E. histolytica and E. dispar in the Venda Region, Limpopo, South Africa. American Journal of Tropical Medicine and Hygiene 2006;75(3):565-571 (Pubitemid 46941327)
261. Stanley SL Jr. Amoebiasis. Lancet 2003;361(9362):1025-1034
262. Tanyuksel M, Petri WA Jr. Laboratory diagnosis of amebiasis. Clinical Microbiology Reviews 2003 Oct;16(4):713-729
263. Tanyuksel M, Yilmaz H, Ulukanligil M, Araz E, Cicek M, Koru O, et al.Comparison of two methods (microscopy and enzyme-linked immunosorbent assay) for the diagnosis of amebiasis. Experimental Parasitology 2005;110(3):322-326 (Pubitemid 40813380)
264. Tarleton JL,Haque R,Mondal D, Shu J, Farr BM, Petri WA Jr. Cognitive effects of diarrhea, malnutrition, and Entamoeba histoltyica infection on school age children in Dhaka, Bangladesh. American Journal of Tropical Medicine and Hygiene 2006;74(3):475-481 (Pubitemid 46774372)
265. Tracy JW, Webster LT Jr. Drugs used in the chemotherapy of protozoal infections: amebiasis, giardiasis, trichomoniasis, leishmaniasis, and other protozoal infections. In: Hardman JG, Limbird LE, Goodman Gilman A editor(s). Goodman & Gilman's the pharmacological basis of therapeutics. 10th Edition. New York: McGraw Hill Medical Publishing Division, 2001:1097-1120
266. Walderich B, Weber A, Knobloch J. Differentiation of Entamoeba histolytica and Entamoeba dispar from German travelers and residents of endemic areas. American Journal of Tropical Medicine and Hygiene 1997;57(1):70-74 (Pubitemid 27305187)
267. Walsh JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Reviews of Infectious Disease 1986;8(2):228-238
268. Wanke C, Butler T, Islam M. Epidemiologic and clinical features of invasive amebiasis in Bangladesh: a case-control comparison with other diarrheal diseases and postmortem findings. American Journal of Tropical Medicine and Hygiene 1988;38:335-341 (Pubitemid 18086115)
269. Wassman C, Hellberg A, Tannich E, Bruchhaus I.Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. Journal of Biological Chemistry 1999;274(37):26051-26056 (Pubitemid 129520027)
270. Weinke T, Friedrich-Janicke B,Hopp P, Janitschke K. Prevalence and clinical importance of Entamoeba histolytica in two high-risk groups: travelers returning from the tropics and male homosexuals. Journal of Infectious Diseases 1990;161(5):1029-1031 (Pubitemid 20148348)
271. WHO Expert Committee on Amoebiasis. Amoebiasis. Report of a WHO Expert Committee. World Health Organization Technical Report Series 1969;421:1-52.
272. World Health Organization. Amoebiasis and its control. A WHO Meeting. Bulletin of the World Health Organization 1985;63(3):417-426
273. World Health Organization. Diarrhoeal Disease Control Programme. The management of bloody diarrhoea in young children [WHO/CDD/94.49]. Geneva: World Health Organization, 1994.
274. World Health Organization. WHO model prescribing information: drugs used in parasitic diseases. 2nd Edition. Geneva: World Health Organization, 1995.
275. World Health Organization/Pan American Health Organization/ UNESCO. Amoebiasis. Weekly Epidemiological Record 1997; 72:97-99
276. World Health Organization. The treatment of diarrhoea: a manual for physicians and other senior health workers [WHO/FCH/CAH/05.1]. 4th Edition. Geneva: World Health Organization, 2005.
277. Woodruff AW, Bell S. The evaluation of amoebicides. Transactions of the Royal Society of Tropical Medicine and Hygiene 1967;61(3):435-9. * Indicates the major publication for the study